Document is current
Any future updates will be listed below
-
Authors
Govrins, Miriam http://orcid.org/0000-0002-7441-4383
Lass-Flörl, Cornelia http://orcid.org/0000-0002-2946-7785
- License Information
-
More Information
Article History
Accepted: 3 August 2023
First Online: 6 September 2023
Competing interests
: M.G. has no competing interests to declare. C.L.-F. reports grant support from Gilead Sciences and Astellas Pharma; has received consulting fees or payment/honoraria for lectures, presentations and educational events from Gilead Sciences, Merck Sharp and Dohme, Pfizer, BioMerieux, F2G and Immy; and has received support for attending meetings and/or travel from Gilead Sciences.
